Indication
Peripheral thyrotoxicosis due to MCT8 deficiency
Peripheral thyrotoxicosis due to monocarboxylate transporter 8 (MCT8) deficiency is a hypermetabolic clinical state occurring in individuals with Allan-Herndon-Dudley syndrome, an X-linked genetic disorder caused by pathogenic mutations in the *SLC16A2* gene. Read more about Peripheral thyrotoxicosis due to MCT8 deficiency
1 drugs 1 manufacturers
Drugs that treat it
Common Peripheral thyrotoxicosis due to MCT8 deficiency therapies.
News & literature
Coming soonRelated codes
Coming soonRelated conditions & guidelines
Coming soonPeripheral thyrotoxicosis due to monocarboxylate transporter 8 (MCT8) deficiency is a hypermetabolic clinical state occurring in individuals with Allan-Herndon-Dudley syndrome, an X-linked genetic disorder caused by pathogenic mutations in the *SLC16A2* gene.
While the loss of functional MCT8 impairs thyroid hormone uptake across the blood-brain barrier—causing central nervous system hypothyroidism and severe neurodevelopmental impairment—non-neural tissues utilize alternate transporters to take up thyroid hormones.
Consequently, marked elevations in circulating free triiodothyronine (T3) excessively stimulate peripheral organ systems, notably the cardiovascular and musculoskeletal systems.
This systemic thyroid hormone excess manifests clinically with chronic tachycardia, progressive muscle wasting, elevated energy expenditure, poor weight gain or failure to thrive, and long-term cardiovascular strain.
- practicalneurology.com
Peripheral thyrotoxicosis due to monocarboxylate transporter 8 (MCT8) deficiency is a hypermetabolic clinical state occurring in individuals with Allan-Herndon-Dudley syndrome, an X-linked genetic disorder caused by pathogenic mutations in the *SLC16A2* gene Consequently, marked elevations in circulating free triiodothyronine (T3) excessively stimulate peripheral organ systems, notably the cardiovascular and musculoskeletal systems This systemic thyroid hormone excess manifests clinically with c...
- nih.gov
Peripheral thyrotoxicosis due to monocarboxylate transporter 8 (MCT8) deficiency is a hypermetabolic clinical state occurring in individuals with Allan-Herndon-Dudley syndrome, an X-linked genetic disorder caused by pathogenic mutations in the *SLC16A2* gene While the loss of functional MCT8 impairs thyroid hormone uptake across the blood-brain barrier—causing central nervous system hypothyroidism and severe neurodevelopmental impairment—non-neural tissues utilize alternate transporters to take ...
- rarediseases.org
While the loss of functional MCT8 impairs thyroid hormone uptake across the blood-brain barrier—causing central nervous system hypothyroidism and severe neurodevelopmental impairment—non-neural tissues utilize alternate transporters to take up thyroid hormones
- drugdiscoverynews.com
Consequently, marked elevations in circulating free triiodothyronine (T3) excessively stimulate peripheral organ systems, notably the cardiovascular and musculoskeletal systems
- europa.eu
This systemic thyroid hormone excess manifests clinically with chronic tachycardia, progressive muscle wasting, elevated energy expenditure, poor weight gain or failure to thrive, and long-term cardiovascular strain
- mct8deficiency.com
This systemic thyroid hormone excess manifests clinically with chronic tachycardia, progressive muscle wasting, elevated energy expenditure, poor weight gain or failure to thrive, and long-term cardiovascular strain
Personalize your experience
Follow Peripheral thyrotoxicosis due to MCT8 deficiency and get updates as they land.
Already a member? Sign in
Follow an indication and get alerts when its drugs, labels, or guidelines change
Save any drug on this page to your favorites, synced across devices
AI-curated peer-reviewed research, summarized for your specialty
A morning digest of indication-relevant updates, when you want it
Sign in to follow this indication
Following an indication requires a free Physicians Office Resource account.